Joseph Broderick
Overview
Explore the profile of Joseph Broderick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
4417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Martins S, MontAlverne F, Rebello L, Abud D, Silva G, Lima F, et al.
N Engl J Med
. 2020 Jun;
382(24):2316-2326.
PMID: 32521133
Background: Randomized trials involving patients with stroke have established that outcomes are improved with the use of thrombectomy for large-vessel occlusion. These trials were performed in high-resource countries and have...
12.
Nogueira R, Lima F, Pontes-Neto O, Silva G, Montalverne F, Abud D, et al.
Int J Stroke
. 2019 Dec;
16(1):100-109.
PMID: 31793395
Background: RESILIENT is a prospective, multicenter, randomized phase III trial to test the safety, efficacy, and cost-effectiveness of mechanical thrombectomy as compared to medical treatment alone in patients treated under...
13.
van t Hof F, Lai D, van Setten J, Bots M, Vaartjes I, Broderick J, et al.
Neurology
. 2019 Nov;
94(5):e481-e488.
PMID: 31732565
Objective: To investigate to what extent low-frequency genetic variants (with minor allele frequencies <5%) affect the risk of intracranial aneurysms (IAs). Methods: One thousand fifty-six patients with IA and 2,097...
14.
Wong G, Daly J, Rhoney D, Broderick J, Ogilvy C, Roos Y, et al.
Neurocrit Care
. 2019 May;
30(Suppl 1):79-86.
PMID: 31077078
Objectives: The goal for the long-term therapies (LTT) working group (WG) of the Unruptured Intracranial Aneurysm (UIA) and Subarachnoid Hemorrhage (SAH) common data elements (CDEs) was to develop a comprehensive...
15.
de Havenon A, Mlynash M, Kim-Tenser M, Lansberg M, Leslie-Mazwi T, Christensen S, et al.
Stroke
. 2019 Feb;
50(3):632-638.
PMID: 30726184
Background and Purpose- The effect of leptomeningeal collaterals for acute ischemic stroke patients with large vessel occlusion in the late window (>6 hours from last known normal) remains unknown. We...
16.
Ton Q, Leino D, Mowery S, Bredemeier N, Lafontant P, Lubert A, et al.
Dis Model Mech
. 2018 Dec;
11(12).
PMID: 30541770
Collagen XXII (COL22A1) is a quantitatively minor collagen, which belongs to the family of fibril-associated collagens with interrupted triple helices. Its biological function has been poorly understood. Here, we used...
17.
Salman R, Frantzias J, Lee R, Lyden P, Battey T, Ayres A, et al.
Lancet Neurol
. 2018 Aug;
17(10):885-894.
PMID: 30120039
Background: Intracerebral haemorrhage growth is associated with poor clinical outcome and is a therapeutic target for improving outcome. We aimed to determine the absolute risk and predictors of intracerebral haemorrhage...
18.
Khatri P, Kleindorfer D, Devlin T, Sawyer Jr R, Starr M, Mejilla J, et al.
JAMA
. 2018 Jul;
320(2):156-166.
PMID: 29998337
Importance: More than half of patients with acute ischemic stroke have minor neurologic deficits (National Institutes of Health Stroke Scale [NIHSS] score of 0-5) at presentation. Although prior major trials...
19.
Nagahama Y, Allan L, Nakagawa D, Zanaty M, Starke R, Chalouhi N, et al.
J Neurosurg
. 2017 Nov;
129(3):702-710.
PMID: 29099296
OBJECTIVE Clinical vasospasm and delayed cerebral ischemia (DCI) are devastating complications of aneurysmal subarachnoid hemorrhage (aSAH). Several theories involving platelet activation have been postulated as potential explanations of the development...
20.
Wang X, Robinson T, Lee T, Li Q, Arima H, Bath P, et al.
JAMA Neurol
. 2017 Oct;
74(11):1328-1335.
PMID: 28973174
Importance: A lower dose of intravenous alteplase appears to be a safer treatment option than the standard dose, reducing the risk of symptomatic intracerebral hemorrhage. There is uncertainty, however, over...